$62B revenue (Paris) manufactures vaccines, oncology therapeutics, and specialty care drugs across 100+ countries. Pursuing AI-driven precision medicine partnerships and digital health infrastructure to compete in next-generation cancer treatment.
Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.
Notes, edit suggestions, or content requests - sent directly to James.